Massey Richard N

Director Richard Massey buys 100,000 ALIT shares at $2.32; stock -70.6% from 52-week high, company posting -$1.1B net income; 3 other insiders buying in cluster.

Director Massey acquired 100,000 shares of Alight at $2.32 on 2025-11-26, establishing his first ALIT position and joining a cluster of 3 other insiders who bought within the past 14 days. The transaction occurs against a severely distressed valuation backdrop: the stock trades -70.6% below its 52-week high of $8.02, has declined -18.1% in the past 30 days and -40.0% in the past 90 days, and the company reported -$1.1B net income with -31.6% annual revenue growth. His prior two buys at ALIT (2025-03-10 and 2023-10-05) yielded a 50% success rate at the 90-day mark (one positive outcome, one negative). The coordinated timing of multiple insiders buying during acute stock weakness and deteriorating fundamentals warrants examination of whether this reflects information asymmetry or is purely reactive to price extremes.

Director Massey Richard N buys 100,000 ALIT shares at $6.39 amid -31.6% revenue decline, -41.6% from 52-week high

Director Massey Richard N purchased 100,000 shares at $6.39, expanding his holdings from 1,473,489 to 1,573,489 shares (+6.8% increase). This purchase occurs against a stark backdrop: ALIT is down -41.6% from its 52-week high of $10.32, trading at $6.03, with annual revenue declining -31.6% year-over-year and the company unprofitable ($-74,000,000 net income in the latest quarter). Notably, this director's prior buy at ALIT on 2023-10-05 delivered a +26.5% 90-day return, his only same-ticker transaction on record. His cross-ticker buy history shows an average 90-day return of +12.6% with a 100% win rate across 3 prior buys, establishing a pattern of favorable post-purchase price performance. The current purchase at a depressed price level—down -8.4% over 30 days and -18.2% over 90 days—follows the stock's significant retreat from recent highs, though the company's deteriorating fundamentals and negative profitability warrant close scrutiny of the underlying business recovery assumptions.